Delivery Order SPE2DB20D3303-SPE2DB24FA2YS

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,175.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, with a completion date of July 2, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $3,454.53, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with a completion date of July 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,731.58 for the supply of FLUTICASONE PROP HFA 44 MCG 10.6GM. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award has no...
This federal contract award, valued at $3,405.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, and has an ultimate completion date of December 21, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.16 firm fixed price delivery order is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,028.06 firm fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM pharmaceutical products. The contract has an ultimate completion date of April 4, 2025 and is not designated as a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,115.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with an ultimate completion date of August 14, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical...
This federal contract award, valued at $4,545.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,929.10 Firm Fixed Price Delivery Order contract covers the procurement of FLUTICASONE PROP HFA 220 MCG 12GM, a pharmaceutical product, with an ultimate completion date of March 11, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,858.86 firm fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA2YS
    Delivery Order

This federal contract award, valued at $18,703.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565740458 - FLUTICASONE PROP HFA 220 MCG 12GM. The contract is a delivery order with a firm fixed price and an ultimate completion date of September 11, 2024. It is not designated as a set-aside contract.

Amerisourcebergen, through its Corporate Office Division, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian agencies, including the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation. These contracts enable the government to efficiently procure essential pharmaceutical and medical supplies from Amerisourcebergen to support the healthcare needs of military personnel, veterans, and other federal beneficiaries across various locations and healthcare settings.

Generated 12/10/24, 2:13 PM